A total of 96 (96/198 or 48.5%) P/LP variants or mutations in BC patients and healthy controls were detected in the BRCA1/2 genes, with 56 mutations in BRCA1 and 40 in BRCA2. This evidence concerns the gene BRCA1 and breast cancer.